gbuk enteral limited
gbuk enteral limited Company Information
Company Number
07186410
Next Accounts
Mar 2026
Shareholders
gbuk group limited
Group Structure
View All
Industry
Manufacture of medical and dental instruments and supplies
Registered Address
woodland house, blackwood hall business park, selby, north yorkshire, YO8 5DD
Website
http://www.gbukgroup.comgbuk enteral limited Estimated Valuation
Pomanda estimates the enterprise value of GBUK ENTERAL LIMITED at £72.7m based on a Turnover of £39.4m and 1.85x industry multiple (adjusted for size and gross margin).
gbuk enteral limited Estimated Valuation
Pomanda estimates the enterprise value of GBUK ENTERAL LIMITED at £109.3m based on an EBITDA of £10.3m and a 10.57x industry multiple (adjusted for size and gross margin).
gbuk enteral limited Estimated Valuation
Pomanda estimates the enterprise value of GBUK ENTERAL LIMITED at £46.8m based on Net Assets of £21m and 2.23x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Gbuk Enteral Limited Overview
Gbuk Enteral Limited is a live company located in selby, YO8 5DD with a Companies House number of 07186410. It operates in the manufacture of medical and dental instruments and supplies sector, SIC Code 32500. Founded in March 2010, it's largest shareholder is gbuk group limited with a 100% stake. Gbuk Enteral Limited is a established, large sized company, Pomanda has estimated its turnover at £39.4m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Gbuk Enteral Limited Health Check
Pomanda's financial health check has awarded Gbuk Enteral Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs
5 Strong
3 Regular
4 Weak
Size
annual sales of £39.4m, make it larger than the average company (£16.8m)
£39.4m - Gbuk Enteral Limited
£16.8m - Industry AVG
Growth
3 year (CAGR) sales growth of 10%, show it is growing at a faster rate (6.2%)
10% - Gbuk Enteral Limited
6.2% - Industry AVG
Production
with a gross margin of 37%, this company has a comparable cost of product (36%)
37% - Gbuk Enteral Limited
36% - Industry AVG
Profitability
an operating margin of 25.8% make it more profitable than the average company (6.1%)
25.8% - Gbuk Enteral Limited
6.1% - Industry AVG
Employees
with 12 employees, this is below the industry average (89)
12 - Gbuk Enteral Limited
89 - Industry AVG
Pay Structure
on an average salary of £96.3k, the company has a higher pay structure (£50.4k)
£96.3k - Gbuk Enteral Limited
£50.4k - Industry AVG
Efficiency
resulting in sales per employee of £3.3m, this is more efficient (£172.6k)
£3.3m - Gbuk Enteral Limited
£172.6k - Industry AVG
Debtor Days
it gets paid by customers after 46 days, this is near the average (51 days)
46 days - Gbuk Enteral Limited
51 days - Industry AVG
Creditor Days
its suppliers are paid after 53 days, this is slower than average (36 days)
53 days - Gbuk Enteral Limited
36 days - Industry AVG
Stock Days
it holds stock equivalent to 146 days, this is more than average (95 days)
146 days - Gbuk Enteral Limited
95 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 9 weeks, this is less cash available to meet short term requirements (13 weeks)
9 weeks - Gbuk Enteral Limited
13 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 41.3%, this is a similar level of debt than the average (41.4%)
41.3% - Gbuk Enteral Limited
41.4% - Industry AVG
GBUK ENTERAL LIMITED financials
Gbuk Enteral Limited's latest turnover from June 2024 is £39.4 million and the company has net assets of £21 million. According to their latest financial statements, Gbuk Enteral Limited has 12 employees and maintains cash reserves of £2.6 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 39,371,000 | 37,717,000 | 34,730,000 | 29,389,000 | 31,739,000 | 27,374,000 | 17,542,000 | 15,240,000 | 12,685,000 | 10,734,000 | 8,365,934 | |||
| Other Income Or Grants | ||||||||||||||
| Cost Of Sales | 24,821,000 | 24,536,000 | 24,551,000 | 19,398,000 | 19,396,000 | 16,712,000 | 11,320,000 | 9,685,000 | 7,230,000 | 5,876,000 | 4,551,954 | |||
| Gross Profit | 14,550,000 | 13,181,000 | 10,179,000 | 9,991,000 | 12,343,000 | 10,662,000 | 6,222,000 | 5,555,000 | 5,455,000 | 4,858,000 | 3,813,980 | |||
| Admin Expenses | 3,445,000 | 3,835,000 | 2,110,754 | |||||||||||
| Operating Profit | 2,010,000 | 1,023,000 | 1,703,226 | |||||||||||
| Interest Payable | 9,423 | |||||||||||||
| Interest Receivable | 1,000 | 127 | ||||||||||||
| Pre-Tax Profit | 9,710,000 | 7,963,000 | 5,333,000 | 5,529,000 | 6,878,000 | 6,091,000 | 2,891,000 | 2,254,000 | 2,011,000 | 1,023,000 | 1,693,930 | |||
| Tax | -1,956,000 | -1,259,000 | -787,000 | -751,000 | -1,015,000 | -879,000 | -522,000 | -171,000 | -33,000 | -455,000 | -406,888 | |||
| Profit After Tax | 7,754,000 | 6,704,000 | 4,546,000 | 4,778,000 | 5,863,000 | 5,212,000 | 2,369,000 | 2,083,000 | 1,978,000 | 568,000 | 1,287,042 | |||
| Dividends Paid | 14,000,000 | 9,000,000 | 650,000 | |||||||||||
| Retained Profit | -6,246,000 | 6,704,000 | 4,546,000 | 4,778,000 | 5,863,000 | -3,788,000 | 2,369,000 | 2,083,000 | 1,978,000 | -82,000 | 1,287,042 | |||
| Employee Costs | 1,155,000 | 1,068,000 | 1,002,000 | 956,000 | 1,021,000 | 756,000 | 735,000 | 671,000 | 725,000 | 810,000 | 571,530 | |||
| Number Of Employees | 12 | 12 | 11 | 11 | 11 | 10 | 11 | 10 | 12 | 18 | 22 | |||
| EBITDA* | 2,069,000 | 1,059,000 | 1,726,596 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 370,000 | 394,000 | 919,000 | 606,000 | 569,000 | 554,000 | 563,000 | 629,000 | 667,000 | 581,000 | 547,476 | 258,563 | 65,080 | 2,517 |
| Intangible Assets | 1,240,000 | 659,000 | 334,000 | 279,000 | 235,000 | 215,000 | 39,000 | 9,000 | 9,000 | |||||
| Investments & Other | 447,000 | |||||||||||||
| Debtors (Due After 1 year) | 49,000 | 1,049,634 | 422,248 | |||||||||||
| Total Fixed Assets | 1,610,000 | 1,053,000 | 1,253,000 | 836,000 | 804,000 | 769,000 | 602,000 | 638,000 | 676,000 | 581,000 | 1,597,110 | 680,811 | 65,080 | 2,517 |
| Stock & work in progress | 9,930,000 | 9,417,000 | 7,497,000 | 7,758,000 | 7,541,000 | 4,457,000 | 2,613,000 | 2,414,000 | 1,757,000 | 976,000 | 994,660 | 854,646 | 433,946 | 291,105 |
| Trade Debtors | 4,973,000 | 3,608,000 | 4,458,000 | 2,822,000 | 3,429,000 | 2,675,000 | 1,744,000 | 1,805,000 | 833,000 | 590,000 | 1,108,214 | 822,443 | 699,531 | 530,245 |
| Group Debtors | 16,080,000 | 22,840,000 | 17,938,000 | 14,809,000 | 1,125,000 | 4,726,000 | 3,299,000 | 1,264,000 | ||||||
| Misc Debtors | 509,000 | 489,000 | 3,183,000 | 1,008,000 | 1,869,000 | 1,446,000 | 683,000 | 150,000 | 129,000 | 326,000 | 268,763 | |||
| Cash | 2,599,000 | 4,050,000 | 3,438,000 | 2,320,000 | 3,547,000 | 1,932,000 | 1,781,000 | 1,410,000 | 1,750,000 | 1,872,000 | 475,037 | 526,259 | 227,640 | 250,983 |
| misc current assets | 2,000 | |||||||||||||
| total current assets | 34,091,000 | 40,404,000 | 36,576,000 | 28,787,000 | 17,511,000 | 10,510,000 | 11,547,000 | 9,078,000 | 5,735,000 | 3,764,000 | 2,846,674 | 2,203,348 | 1,361,117 | 1,072,333 |
| total assets | 35,701,000 | 41,457,000 | 37,829,000 | 29,623,000 | 18,315,000 | 11,279,000 | 12,149,000 | 9,716,000 | 6,411,000 | 4,345,000 | 4,443,784 | 2,884,159 | 1,426,197 | 1,074,850 |
| Bank overdraft | 379,480 | |||||||||||||
| Bank loan | 347,148 | |||||||||||||
| Trade Creditors | 3,671,000 | 2,866,000 | 3,339,000 | 1,807,000 | 2,505,000 | 2,026,000 | 1,124,000 | 2,575,000 | 790,000 | 524,000 | 421,060 | 755,138 | 488,091 | 483,106 |
| Group/Directors Accounts | 8,007,000 | 8,635,000 | ||||||||||||
| other short term finances | ||||||||||||||
| hp & lease commitments | ||||||||||||||
| other current liabilities | 3,010,000 | 2,804,000 | 12,050,000 | 12,270,000 | 3,367,000 | 2,745,000 | 1,149,000 | 81,000 | 670,000 | 878,000 | 625,777 | |||
| total current liabilities | 14,688,000 | 14,305,000 | 15,389,000 | 14,077,000 | 5,872,000 | 4,771,000 | 2,273,000 | 2,656,000 | 1,460,000 | 1,402,000 | 1,393,985 | 1,134,618 | 488,091 | 483,106 |
| loans | 64,000 | 95,612 | ||||||||||||
| hp & lease commitments | ||||||||||||||
| Accruals and Deferred Income | 101,000 | |||||||||||||
| other liabilities | 80,000 | 140,807 | 149,081 | 199,947 | ||||||||||
| provisions | 48,000 | 120,000 | 1,066,000 | 600,000 | 530,000 | 376,000 | 117,000 | 112,000 | 105,131 | 46,720 | ||||
| total long term liabilities | 48,000 | 200,000 | 533,000 | 300,000 | 265,000 | 188,000 | 101,000 | 117,000 | 176,000 | 200,743 | 187,527 | 149,081 | 199,947 | |
| total liabilities | 14,736,000 | 14,505,000 | 15,922,000 | 14,077,000 | 6,172,000 | 5,036,000 | 2,461,000 | 2,757,000 | 1,577,000 | 1,578,000 | 1,594,728 | 1,322,145 | 637,172 | 683,053 |
| net assets | 20,965,000 | 26,952,000 | 21,907,000 | 15,546,000 | 12,143,000 | 6,243,000 | 9,688,000 | 6,959,000 | 4,834,000 | 2,767,000 | 2,849,056 | 1,562,014 | 789,025 | 391,797 |
| total shareholders funds | 20,965,000 | 26,952,000 | 21,907,000 | 15,546,000 | 12,143,000 | 6,243,000 | 9,688,000 | 6,959,000 | 4,834,000 | 2,767,000 | 2,849,056 | 1,562,014 | 789,025 | 391,797 |
| Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | 2,010,000 | 1,023,000 | 1,703,226 | |||||||||||
| Depreciation | 80,000 | 80,000 | 93,000 | 108,000 | 106,000 | 99,000 | 75,000 | 71,000 | 59,000 | 36,000 | 23,370 | 3,325 | 3,325 | |
| Amortisation | 98,000 | 63,000 | 38,000 | 33,000 | 24,000 | 17,000 | ||||||||
| Tax | -1,956,000 | -1,259,000 | -787,000 | -751,000 | -1,015,000 | -879,000 | -522,000 | -171,000 | -33,000 | -455,000 | -406,888 | |||
| Stock | 513,000 | 1,920,000 | -261,000 | 217,000 | 3,084,000 | 1,844,000 | 199,000 | 657,000 | 781,000 | -18,660 | 140,014 | 420,700 | 142,841 | 291,105 |
| Debtors | -5,375,000 | 1,358,000 | 6,891,000 | 12,265,000 | 2,302,000 | -3,032,000 | 1,899,000 | 3,028,000 | 1,310,000 | -1,510,611 | 1,181,920 | 545,160 | 169,286 | 530,245 |
| Creditors | 805,000 | -473,000 | 1,532,000 | -698,000 | 479,000 | 902,000 | -1,451,000 | 1,785,000 | 266,000 | 102,940 | -334,078 | 267,047 | 4,985 | 483,106 |
| Accruals and Deferred Income | 206,000 | -9,246,000 | -220,000 | 8,903,000 | 622,000 | 1,596,000 | 967,000 | -488,000 | -208,000 | 252,223 | 625,777 | |||
| Deferred Taxes & Provisions | -72,000 | -946,000 | 1,066,000 | -600,000 | 70,000 | 154,000 | 376,000 | -117,000 | 5,000 | 6,869 | 58,411 | 46,720 | ||
| Cash flow from operations | 8,000 | 2,495,303 | 347,884 | |||||||||||
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | -447,000 | 447,000 | ||||||||||||
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | -347,148 | 347,148 | ||||||||||||
| Group/Directors Accounts | -628,000 | 8,635,000 | ||||||||||||
| Other Short Term Loans | ||||||||||||||
| Long term loans | -64,000 | -31,612 | 95,612 | |||||||||||
| Hire Purchase and Lease Commitments | ||||||||||||||
| other long term liabilities | -80,000 | 80,000 | -140,807 | -8,274 | -50,866 | 199,947 | ||||||||
| share issue | ||||||||||||||
| interest | 1,000 | -9,296 | ||||||||||||
| cash flow from financing | -449,000 | 7,056,000 | 1,815,000 | -1,375,000 | 37,000 | 343,000 | 360,000 | 42,000 | 26,000 | -378,816 | 292,657 | |||
| cash and cash equivalents | ||||||||||||||
| cash | -1,451,000 | 612,000 | 1,118,000 | -1,227,000 | 1,615,000 | 151,000 | 371,000 | -340,000 | -122,000 | 1,396,963 | -51,222 | 298,619 | -23,343 | 250,983 |
| overdraft | -379,480 | 379,480 | ||||||||||||
| change in cash | -1,451,000 | 612,000 | 1,118,000 | -1,227,000 | 1,615,000 | 151,000 | 371,000 | -340,000 | -122,000 | 1,396,963 | 328,258 | -80,861 | -23,343 | 250,983 |
gbuk enteral limited Credit Report and Business Information
Gbuk Enteral Limited Competitor Analysis
Perform a competitor analysis for gbuk enteral limited by selecting its closest rivals, whether from the MANUFACTURING sector, other large companies, companies in YO8 area or any other competitors across 12 key performance metrics.
gbuk enteral limited Ownership
GBUK ENTERAL LIMITED group structure
Gbuk Enteral Limited has no subsidiary companies.
Ultimate parent company
ENHANCING PATIENT CARE JERSEY TOPCO LTD
#0155578
2 parents
GBUK ENTERAL LIMITED
07186410
gbuk enteral limited directors
Gbuk Enteral Limited currently has 4 directors. The longest serving directors include Mr Peter Spiller (Nov 2015) and Mr Michael Geering (Sep 2017).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Peter Spiller | England | 45 years | Nov 2015 | - | Director |
| Mr Michael Geering | England | 53 years | Sep 2017 | - | Director |
| Mr Guy Dew | England | 44 years | Apr 2019 | - | Director |
| Mr Mark Hall | England | 53 years | Jan 2025 | - | Director |
P&L
June 2024turnover
39.4m
+4%
operating profit
10.2m
0%
gross margin
37%
+5.75%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2024net assets
21m
-0.22%
total assets
35.7m
-0.14%
cash
2.6m
-0.36%
net assets
Total assets minus all liabilities
gbuk enteral limited company details
company number
07186410
Type
Private limited with Share Capital
industry
32500 - Manufacture of medical and dental instruments and supplies
incorporation date
March 2010
age
15
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
June 2024
previous names
N/A
accountant
-
auditor
GRANT THORNTON UK LLP
address
woodland house, blackwood hall business park, selby, north yorkshire, YO8 5DD
Bank
HSBC UK BANK PLC
Legal Advisor
-
gbuk enteral limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 5 charges/mortgages relating to gbuk enteral limited. Currently there are 1 open charges and 4 have been satisfied in the past.
gbuk enteral limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for GBUK ENTERAL LIMITED. This can take several minutes, an email will notify you when this has completed.
gbuk enteral limited Companies House Filings - See Documents
| date | description | view/download |
|---|
